Imperative Care names Ariel Sutton GM of stroke business
03 Apr 2023
Executive Change
Campbell, California-based Imperative Care develops connected technology to treat stroke and other ischemic diseases. Sutton initially joined the company as EVP of marketing in August 2016.
“I am honored to take on this new role as Imperative Care continues to drive a patient-first approach to stroke treatment,” said Sutton. “Our approach has always been to focus on the needs of the patient and to work closely with physicians to rapidly iterate our product. Our commitment to addressing urgent clinical needs in collaboration with physicians has enabled us to continually elevate patient outcomes. I am excited to have this opportunity as Imperative Care advances toward its next chapter of growth.”
Since joining in 2016, Sutton played an “instrumental role” in leading the company through the competitive stroke care market.
Before that, she held marketing and product management roles at Cardinal Health, Access Closure and ev3. She also had similar positions at FoxHollow Technologies and Johnson & Johnson’s LifeScan.
“Under Ariel’s leadership, Imperative Care has remained focused on elevating care and bringing life-saving technologies to patients affected by stroke,” said Daniel Davis, president and COO. “Ariel’s dedication to excellence is unwavering, and I am looking forward to her leading Imperative Stroke through our next chapter as we continue to expand our clinical impact.”
Imperative Care develops the Zoom stroke solution product platform to usher in a new era of stroke thrombectomy. It enables fast and consistent treatment, plus improved procedure outcomes. Through reperfusion, physicians and perform fast, effective clot removal in patients with ischemic stroke.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.